JPRN-UMIN000047368Completed未知
Immune Persistence and Safety Pediatric Survey (Aged 5-11 Years) related to the SARS-CoV-2 Vaccination (Primary series and Booster Vaccination) in Japan - Immune Persistence and Safety Pediatric Cohort Survey on SARS-CoV-2 Vaccination in Japan
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Juntendo University
- Enrollment
- 411
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 5years-old to 11years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Those who are inappropriate as the subject of the survey determined by the principal investi gator.
Investigators
Similar Trials
Completed
Not Applicable
Immune persistence and safety survey (cohort survey) related to the first series of new corona recombinant protein vaccines and boostersCOVID-19JPRN-UMIN000047920Juntendo University579
Completed
Unknown
Immune Persistence and Safety Survey (Cohort Survey) related to the Bivalent SARS-CoV-2 Booster Vaccination in JapaCOVID-19JPRN-UMIN000049533Juntendo University2,848
Completed
Not Applicable
Immune Persistence and Safety Survey (Cohort Survey) related to the SARS-CoV-2 Booster Vaccination (4th dose) in JapaCOVID-19JPRN-UMIN000047919Juntendo University3,441
Unknown
Phase 3
Trail To Evaluate the Immune Effects of Primary and Booster Immunizations With Poliovirus VaccinePoliomyelitisNCT03821441Chinese Academy of Medical Sciences1,165
Completed
Not Applicable
Meningococcal C Conjugate Brazilian Vaccine ProjectMeningitisISRCTN72642831The Immunobiological Technology Institute (Bio-Manguinhos) (Brazil)360